Importance of expert central review in the diagnosis of lymphoid malignancies in a regional cancer network

Journal of Clinical Oncology

Volumn 29, Issue 11, 2011, Pages 1431-1435

  Proctor, Ian E ^a,b,c   McNamara, Christopher ^a,b   Rodriguez Justo, Manuel ^a,b   Isaacson, Peter G ^a,b   Ramsay, Alan ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c Rockefeller Bldg   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CANCER THERAPY; COST; DIAGNOSTIC ACCURACY; EXPERT CENTRAL REVIEW; FOLLICULAR LYMPHOMA; HASHIMOTO DISEASE; HEALTH CARE MANAGEMENT; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOMA; LYMPHOPLASMACYTIC LYMPHOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PLASMACYTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

CLINICAL TRIALS AS TOPIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; LONDON; LYMPHOMA; PATHOLOGY; PATIENT CARE PLANNING; PEER REVIEW; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 79955012061     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.31.2223     Document Type: Review

References (14)

1. Jaffe ES: World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (ed 3). Lyon, France, IARC Press, 2001
2. Troxel DB: Error in surgical pathology. Am J Surg Pathol 28:1092-1095, 2004 (Pubitemid 38971435)
3. National Institute for Health and Clinical Excellence: Improving outcomes in haematological cancers. http://www.nice.org.uk/docref.asp?d-90429
4. Bird CC, Lauder I, Kellett HS, et al: Yorkshire Regional Lymphoma Histopathology panel: Analysis of five years' experience. J Pathol 143:249-258, 1984 (Pubitemid 14048870)
5. Dick FR, VanLier SF, McKeen K, et al: Nonconcurrence in abstracted diagnoses of non-Hodgkin's lymphoma. J Natl Cancer Inst 78:675-678, 1987 (Pubitemid 17063624)
6. Wolf BC, Gilchrist KW, Mann RB, et al: Evaluation of pathology review of malignant lymphomas and Hodgkin's disease in cooperative clinical trials: The Eastern Cooperative Oncology Group experience. Cancer 62:1301-1305, 1988
7. Youngson JH, Jones JM, Chang JG, et al: Treatment and survival of lymphoid malignancy in the north-west of England: A population-based study. Br J Cancer 72:757-765, 1995
8. Siebert JD, Harvey LA, Fishkin PA, et al: Comparison of lymphoid neoplasm classification: A blinded study between a community and an academic setting. Am J Clin Pathol 115:650-655, 2001 (Pubitemid 33051530)
9. Lester JF, Dojcinov SD, Attanoos RL, et al: The clinical impact of expert pathological review on lymphoma management: A regional experience. Br J Haematol 123:463-468, 2003 (Pubitemid 37363487)
10. LaCasce AS, Kho ME, Friedberg JW, et al: Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network. J Clin Oncol 26: 5107-5112, 2008
11. Swerdlow SH: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed 4). Lyon, France, IARC Press, 2008
12. United Kingdom National External Quality Assessment Service for Immunocytochemistry and In-Situ Hybridisation. Homepage. http://www.ukneqasicc. ucl.ac uk
13. Lee RC, Zou D, Demetrick DJ, et al: Costs associated with diffuse large B-cell lymphoma patient treatment in a Canadian integrated cancer care center. Value Health 11:221-230, 2008 (Pubitemid 351473604)
14. Richards SJ, Jack AS: The development of integrated haematopathology laboratories: A new approach to the diagnosis of leukaemia and lymphoma. Clin Lab Haematol 25:337-342, 2003 (Pubitemid 37521979)